Firstly, to be clear, I was not suggesting similarities between...

Firstly, to be clear, I was not suggesting similarities between VLA and NEU. Different type of assets, different stage of development (NEU is much more mature), vastly different revenue streams and cash positions, different Boards….

My post was in reply to gingerclam’s post about how games can be played in the market to ‘soften up” shareholders – something previously alluded to by Little T.

I wanted to provide what I see as an ASX biotech example of this “softening up” process, backed by a few facts.

The intention was simply to alert, not alarm, those unfamiliar with or dismissive of these kinds of tactical plays. Forewarned is forearmed.

Secondly, thank you Mr_Cod and others for the kind words and recognition, which I do appreciate. But I would kindly request that the focus stay less on me and more on the more important issues. Thanks.